ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
112 hedge funds and large institutions have $431M invested in Array Biopharma Inc in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 35 increasing their positions, 33 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
57% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 28
Holders
112
Holding in Top 10
3
Calls
$1.81M
Puts
$2.53M
Top Buyers
| 1 | +$5.09M | |
| 2 | +$4.03M | |
| 3 | +$3.83M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.1M |
| 5 |
QF
QVT Financial
New York
|
+$1.05M |
Top Sellers
| 1 | -$3M | |
| 2 | -$2.13M | |
| 3 | -$1.78M | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$1.08M |
| 5 |
ARC
Absolute Return Capital
Boston,
Massachusetts
|
-$817K |